This work was undertaken to examine whether human synovium could be engraft
ed into subcutaneous pouches in the ears of severe combined immunodeficient
(SCID) mice. Synovium was transplanted into surgically constructed ear pou
ches. The grafts were examined by histological and immunohistochemical meth
ods after varying periods after engraftment, or after percutaneous injectio
n of TNF-alpha. Normal, osteo-arthritic and rheumatoid synovium was engraft
ed successfully in subcutaneous ear pouches. The general morphology and cel
lular compositions of xenografts were retained including human endothelial
cells. In rheumatoid xenografts, macrophages, fibroblasts and lymphocytes p
ersisted for at least 4 weeks. Vascular expression of intercellular adhesio
n molecule-1 (ICAM-1) was maintained but expression of vascular adhesion mo
lecule-1 (VCAM-1), E-selectin and MHC class II diminished with time. Percut
aneous injection of TNF-a induced up-regulation of VCAM-1. Human synovium c
an be engrafted into subcutaneous ear pouches in SCID mice. The xenografts
are accessible and respond to injection of a pro-inflammatory cytokine.